Study period | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phase | Screening | Study Treatment | Follow-up | ||||||||||||||
Timepoint | W-8 to D-1 | D1/BSL | W2 | W4 | W8 | W12 | W16 | W20 | W24 | W28 | W32 | W36 | W40 | W52 | W64 | W76 | W88 |
Enrolment: | |||||||||||||||||
Screening | |||||||||||||||||
Informed consent | X | ||||||||||||||||
Inclusion/exclusion criteria | X | ||||||||||||||||
Chest CT | X | X | X | X | |||||||||||||
Medical history and demographics | X | ||||||||||||||||
Pregnancy test | X | X | X | X | |||||||||||||
HIV test | X | ||||||||||||||||
Symptoms/weight | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
Physical examination | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
Randomization | X | ||||||||||||||||
Interventions: | |||||||||||||||||
Dispense/administer allocated TB treatment | X | X | X | X | X | X | X | X | X | X | X | X | |||||
Assessments: | |||||||||||||||||
Study treatment adherence assessment | X | X | X | X | X | X | X | X | X | X | X | X | |||||
Efficacy and safety evaluations | |||||||||||||||||
Sputum smear | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
Sputum culture | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
Molecular DST | X | ||||||||||||||||
Collect strains for phenotypic DST (only in case of positive sputum culture) | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
Visual acuity testing | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||
Urinalysis | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||
Hematology | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||
Clinical chemistrya | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||
Hepatitis B and C testing | X | ||||||||||||||||
TSHb | X | X | X | X | |||||||||||||
ECGc | X | X | X | X | X | X | X | X | X | X | X | X | X | ||||
Ongoing participant review | |||||||||||||||||
Concomitant therapy | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
AEs | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |